胶质母细胞瘤长期生存的预后因素。
Prognostic factors for long-term survival after glioblastoma.
作者信息
Walid Mohammad Sami
出版信息
Perm J. 2008 Fall;12(4):45-8. doi: 10.7812/TPP/08-027.
Abstract
Long-term survivors of glioblastoma (GB) are rare. Several variables besides tumor size and location determine a patient's survival chances: age at diagnosis, where younger patients often receive more aggressive treatment that is multimodal; functional status, which has a significant negative correlation with age; and histologic and genetic markers.
摘要
胶质母细胞瘤（GB）的长期幸存者很罕见。除了肿瘤大小和位置外，还有几个变量决定患者的生存机会：诊断时的年龄，年轻患者通常接受更积极的多模式治疗；功能状态，与年龄呈显著负相关；以及组织学和基因标志物。
相似文献
1
Prognostic factors for long-term survival after glioblastoma.胶质母细胞瘤长期生存的预后因素。
Perm J. 2008 Fall;12(4):45-8. doi: 10.7812/TPP/08-027.
2
Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?年龄调整后的 Charlson 共病指数在复发性脑胶质瘤中的应用：一种新的预后因素？
BMC Neurol. 2022 Jan 21;22(1):32. doi: 10.1186/s12883-021-02532-x.
3
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?胶质母细胞瘤长期存活者与短期存活者的比较：脑室下区受累情况——生存的预测因素？
Radiat Oncol. 2014 Apr 23;9:95. doi: 10.1186/1748-717X-9-95.
4
Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009.成人小脑胶质母细胞瘤：使用 1973 年至 2009 年的基于人群的数据库了解生存和预后因素。
World Neurosurg. 2013 Dec;80(6):e237-43. doi: 10.1016/j.wneu.2013.02.010. Epub 2013 Feb 6.
5
Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset.胶质母细胞瘤短期生存者与长期生存者的对比：澳大利亚数据集综述
Asia Pac J Clin Oncol. 2014 Jun;10(2):153-61. doi: 10.1111/ajco.12076. Epub 2013 May 22.
6
Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?颅内多形性胶质母细胞瘤患者的长期生存率是否被高估了？
Cancer. 2003 Oct 15;98(8):1745-8. doi: 10.1002/cncr.11666.
7
Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.多形性胶质母细胞瘤长期存活者中PTEN、TP53和CDKN2A肿瘤抑制基因的分子分析。
J Neurooncol. 2000 Jun;48(2):89-94. doi: 10.1023/a:1006402614838.
8
[A clinical and molecular study of long-term survival glioblastomas].[长期存活胶质母细胞瘤的临床与分子研究]
Zhonghua Wai Ke Za Zhi. 2013 Feb 1;51(2):166-70.
9
Long-term glioblastoma multiforme survivors: a population-based study.多形性胶质母细胞瘤长期幸存者：一项基于人群的研究。
Can J Neurol Sci. 1998 Aug;25(3):197-201. doi: 10.1017/s0317167100034016.
10
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.替莫唑胺长期治疗是新诊断胶质母细胞瘤的一种可行选择：一家机构多达101个替莫唑胺疗程的经验。
Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.
引用本文的文献
1
The role of the Ki-67 labelling index as an independent prognostic factor in indonesian glioma patients.Ki-67标记指数作为印度尼西亚胶质瘤患者独立预后因素的作用。
Histol Histopathol. 2025 Jun;40(6):835-842. doi: 10.14670/HH-18-833. Epub 2024 Oct 15.
2
Synthesis, Cytotoxicity, and Mechanistic Evaluation of Tetrahydrocurcumin-Amino Acid Conjugates as LAT1-Targeting Anticancer Agents in C6 Glioma Cells.四氢姜黄素-氨基酸缀合物的合成、细胞毒性及作为 C6 神经胶质瘤细胞中 LAT1 靶向抗癌剂的作用机制评价。
Int J Mol Sci. 2024 Oct 19;25(20):11266. doi: 10.3390/ijms252011266.
3
Expression and prognostic significance of microsomal triglyceride transfer protein in brain tumors: a retrospective cohort study.微粒体甘油三酯转运蛋白在脑肿瘤中的表达及预后意义：一项回顾性队列研究
Transl Cancer Res. 2024 May 31;13(5):2282-2294. doi: 10.21037/tcr-23-2286. Epub 2024 May 28.
4
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma.整合计算流程以简化胶质母细胞瘤中有效药物提名和生物标志物发现
Cancers (Basel). 2024 Apr 28;16(9):1723. doi: 10.3390/cancers16091723.
5
Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.LINC00324 的失调促进了胶质瘤患者的不良预后。
PLoS One. 2024 Mar 26;19(3):e0298055. doi: 10.1371/journal.pone.0298055. eCollection 2024.
6
The Prognostic Role of Volumetric MRI Evaluation in the Surgical Treatment of Glioblastoma.容积磁共振成像评估在胶质母细胞瘤外科治疗中的预后作用
J Clin Med. 2024 Feb 1;13(3):849. doi: 10.3390/jcm13030849.
7
Naturopathic Treatment of Grade III Oligodendroglioma With Progression to Grade IV Isocitrate Dehydrogenase (IDH)-Mutant Astrocytoma and the Development of Spinal Gliomatosis.以自然疗法治疗进展为IV级异柠檬酸脱氢酶（IDH）突变型星形细胞瘤的III级少突胶质细胞瘤及脊髓胶质瘤病的发生
Cureus. 2023 Sep 19;15(9):e45526. doi: 10.7759/cureus.45526. eCollection 2023 Sep.
8
Brain endothelial cell-derived extracellular vesicles with a mitochondria-targeting photosensitizer effectively treat glioblastoma by hijacking the blood‒brain barrier.携带线粒体靶向光敏剂的脑内皮细胞衍生细胞外囊泡通过劫持血脑屏障有效治疗胶质母细胞瘤。
Acta Pharm Sin B. 2023 Sep;13(9):3834-3848. doi: 10.1016/j.apsb.2023.03.023. Epub 2023 Mar 31.
9
A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors.比较不同的机器学习技术，以选择一组允许早期检测脑肿瘤的代谢物。
Sci Rep. 2023 Jul 8;13(1):11044. doi: 10.1038/s41598-023-38243-1.
10
The Brain Tumor Segmentation (BraTS) Challenge 2023: .2023年脑肿瘤分割（BraTS）挑战赛：
ArXiv. 2023 May 30:arXiv:2305.19369v1.
本文引用的文献
1
Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.基因组表达模式区分长期与短期胶质母细胞瘤幸存者：一项初步可行性研究。
Genomics. 2008 May;91(5):395-406. doi: 10.1016/j.ygeno.2008.01.002. Epub 2008 Mar 17.
2
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.放疗联合同步及辅助替莫唑胺治疗老年胶质母细胞瘤患者。
J Neurooncol. 2008 May;88(1):97-103. doi: 10.1007/s11060-008-9538-0. Epub 2008 Feb 5.
3
Molecular genetic markers as predictors of response to chemotherapy in gliomas.分子遗传标志物作为胶质瘤化疗反应的预测指标。
Curr Opin Oncol. 2007 Nov;19(6):606-11. doi: 10.1097/CCO.0b013e3282f075f3.
4
Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy.巧合与因果关系：三例接受近距离放射治疗的胶质母细胞瘤患者的治愈情况
Can J Neurol Sci. 2007 Aug;34(3):339-42. doi: 10.1017/s031716710000679x.
5
Long-term survival with glioblastoma multiforme.多形性胶质母细胞瘤的长期生存
Brain. 2007 Oct;130(Pt 10):2596-606. doi: 10.1093/brain/awm204. Epub 2007 Sep 4.
6
MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.O6-甲基鸟嘌呤-DNA甲基转移酶对胶质母细胞瘤的预后影响取决于治疗方式。
J Neurooncol. 2007 Jun;83(2):173-9. doi: 10.1007/s11060-006-9320-0. Epub 2007 Jan 12.
7
Primary glioblastoma multiforme in younger patients: a single-institution experience.年轻患者的原发性多形性胶质母细胞瘤：单机构经验
Tumori. 2006 Sep-Oct;92(5):407-11. doi: 10.1177/030089160609200507.
8
9
The burden of radiation-induced central nervous system tumors: a single institution s experience.
J Neuropathol Exp Neurol. 2006 Mar;65(3):204-16. doi: 10.1097/01.jnen.0000205146.62081.29.
10
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.O6-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化与儿童胶质母细胞瘤的生存获益及对替莫唑胺的敏感性相关。
Pediatr Blood Cancer. 2007 Apr;48(4):403-7. doi: 10.1002/pbc.20803.
Zotero 插件